Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase I Study of MB-CART19.1 Cellular Therapy for Relapsed/Refractory Primary and Secondary Central Nervous System Lymphoma (CNSL) Using On- Site Manufacturing With the CliniMACS Prodigy Device

This study will test whether MB-CART19.1 is a safe and effective treatment for central nervous system lymphoma (CNSL). This study will test different doses of …

Primary Central Nervous System (CNS) LymphomaSecondary Central Nervous System Lymphoma

Memorial Sloan Kettering Cancer CenterNCT07137494